On the other hand, there is evidence that MCP-1 is produced in the kidneys and the renal production of MCP-1 may be increased in a number of conditions, including diabetic nephropathy and systemic lupus erithematosus [16]. Here, CCL2 is linked to diabetic kidney disease.